In this follow-up study, virological response to and adverse event profile of bictegravir/emtricitabine/tenofovir alafenamide (B/F/TAF) was assessed at 240 weeks. >98% of people with HIV who received B/F/TAF maintained an HIV-1 RNA of
This content supports the SDG Goal 3: Good health and well-being by examining current hepatitis B vaccines as a solution toward the elimiation of HBV as a public health treat.
This study calls for research on how to address the spiritual needs of healthy and sick populations.
Background: The Global Burden of Disease Study (GBD) estimates burden by cause with major relevance for resource allocators globally. Non-fatal burden estimates are influenced by disorder severity.
This chapter aligns with Goal 14: Life Below Water and Goal 3: Good Health and Wellbeing by highlighting some of the many beneficial industrial and pharmaceutical applications of marine microalgae.
Elsevier,
Clinical Lipidology (Third Edition): A Companion to Braunwald's Heart Disease, 2024, Pages 383-390.e2
This content aligns with Goal 3: Good Health and Wellbeing by highlighting the increased cardiovascular risk before initiation or after changes of HIV treatment.
The findings of this study suggest further review and consideration of a multipronged approach of integrated nutrition, menstrual hygiene management, and water, sanitation and hygiene interventions at the school level to improve adolescent nutrition and health.
